(Q73273610)
Statements
Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A (English)
H Juhl
F Helmig
K Baltzer
H Kalthoff
D Henne-Bruns